Amersham International plc's acquisition of United StatesBiochemical Corp. (USB) became a matter of record April 2, thestart of Amersham's new fiscal year.

The acquisition, announced March 15, is potentially worth $69million. USB of Cleveland received $51.75 million of that uponcompletion of the acquisition. The remainder -- up to $17.25million -- will be paid over the next three years contingent onagreed-upon sales levels of certain of USB's products.

Vector Securities International Inc. initiated the transaction,assisted in the negotiations and acted as exclusive financialadviser to USB. Amersham's bankers are Morgan Grenfell & Co.Ltd.

(c) 1997 American Health Consultants. All rights reserved.